BeOne Medicines AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US07725L1026
€ 236,00 ↑2.00 (0.85%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:49BA / BeOne Medicines AG - Depositary Receipt (Common Stock)
InstitutionM&G Plc
Latest Disclosed Ownership138,163 shares
Latest Disclosed Value $ 41,034,411
M&G Plc reports 6.45% increase in ownership of 49BA / BeOne Medicines AG - Depositary Receipt (Common Stock)

On May 13, 2026 - M&G Plc filed a 13F-HR form disclosing ownership of 138,163 shares of BeOne Medicines AG - Depositary Receipt (Common Stock) (DE:49BA) valued at $34,264,424 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 129,791 shares of BeOne Medicines AG - Depositary Receipt (Common Stock). This represents a change in shares of 6.45% during the quarter. The current value of the position is $32,606,468 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 138,163 8,372 6.45 41,034 4.00 0.1625
2026-02-12 2025-12-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 129,791 9,070 7.51 39,456 -4.15 0.2027
2025-11-07 2025-09-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 120,721 -49,481 -29.07 41,166 -0.06 0.2189
2025-08-08 2025-06-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 170,202 -15,829 -8.51 41,189 -18.60 0.2269
2025-05-13 2025-03-31 13F BEIGENE SPONSORED ADS 07725L102 186,031 -7,132 -3.69 50,600 41.60 0.2421
2025-02-11 2024-12-31 13F BEIGENE SPONSORED ADR 07725L102 193,163 20,088 11.61 35,735 -8.23 0.2206
2024-10-31 2024-09-30 13F BEIGENE SPONSORED ADR 07725L102 173,075 -6,704 -3.73 38,942 51.47 0.1582
2024-07-16 2024-06-30 13F BEIGENE SPONSORED ADR 07725L102 179,779 -10,277 -5.41 25,708 -13.29 0.1015
2024-05-10 2024-03-31 13F BEIGENE SPONSORED ADR 07725L102 190,056 190,056 29,649 0.1121
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.